susan buchbinder. >> thank you. so i'm going to talk to you about covid vaccine studies that we are sort of more looking at globally about what is happening nationally and internationally, as well what we are planning to do here. next slide. so what is it that we're hoping that a covid vaccine could do? well, we're hoping that it would benefit the individual by maybe preventing all infection in addition to just the sevirrity f illness and to create healthier communities. next slide. so this is an electron micrograph of the covid -- the virus that causes covid. it's called a coronavirus because it has this crown or circle of light that is made up of these spiked proteins that you can see illustrated on the right. and virtually -- most of the vaccines that are being developed are really being targeted against this pro fine. and i'll show you why in just a moment. next slide. so this is a virus shown on the lefthand side of the slide and the human receptor shown on the right hand of the slide, a human cell. the recepto

susan buchbinder. >> thank you. so i'm going to talk to you about covid vaccine studies that we are sort of more looking at globally about what is happening nationally and internationally, as well what we are planning to do here. next slide. so what is it that we're hoping that a covid vaccine could do? well, we're hoping that it would benefit the individual by maybe preventing all infection in addition to just the sevirrity f illness and to create healthier communities. next slide. so this is an electron micrograph of the covid -- the virus that causes covid. it's called a coronavirus because it has this crown or circle of light that is made up of these spiked proteins that you can see illustrated on the right. and virtually -- most of the vaccines that are being developed are really being targeted against this pro fine. and i'll show you why in just a moment. next slide. so this is a virus shown on the lefthand side of the slide and the human receptor shown on the right hand of the slide, a human cell. the recepto

susan buchbinder. >> thank you. talk to you about covid vaccine studies that we are sort of more looking at globally about what is happening nationally and internationally, as well what we are planning to do here. next slide. so what is it that we're hoping that a covid vaccine could do? well, we're hoping that it would benefit the individual by maybe preventing all infection in addition to just the sevirrity f illness and to create healthier communities. next slide. so this is an electron micrograph of the covid -- the virus that causes covid. it's called a coronavirus because it has this crown or circle of light that is made up of these spiked proteins that you can see illustrated on the right. and virtually -- most of the vaccines that are being developed are really being targeted against this pro fine. and i'll show you why in just a moment. next slide. so this is a virus shown on the lefthand side of the slide and the human receptor shown on the right hand of the slide, a human cell. the receptor is the lock th

susan buchbinder. >> thank you.o i'm going to talk to you about covid vaccine studies that we are sort of more looking at globally about what is happening nationally and internationally, as well what we are planning to do here. next slide. so what is it that we're hoping that a covid vaccine could do? well, we're hoping that it would benefit the individual by maybe preventing all infection in addition to just the sevirrity f illness and to create healthier communities. next slide. so this is an electron micrograph of the covid -- the virus that causes covid. it's called a coronavirus because it has this crown or circle of light that is made up of these spiked proteins that you can see illustrated on the right. and virtually -- most of the vaccines that are being developed are really being targeted against this pro fine. and i'll show you why in just a moment. next slide. so this is a virus shown on the lefthand side of the slide and the human receptor shown on the right hand of the slide, a human cell. the receptor

next, we will hear from aaron buchbinder. are you here? we will hear from oi-yee wong. ms. wong available? then last but not least, sara shortt. are you here? there you are. good morning. >> good morning. i'm just super excited about mental health sf. i'm passionate about being involved in the implementation. i'll tell you why. i think it was probably when i graduated with my masters in social work about 20 years ago when i first started to understand some of the challenges with our mental healthcare system. i knew a bit about it before that. i do have an uncle who's chronically mentally ill. family has been working to get decent care for decades -- understood firsthand all the barriers and the challenges and the obstacles. but also how important it was for him to get decent care. care that emphasized things like harm restructure, care that was sensitive -- coordinated, compassionate. that's what we're talking about with mental health sf. i'm also excited about it because as a member of the treatment on demand coalition, we've been working on the issue of reform for behavio

next, we will hear from aaron buchbinder. are you here? we will hear from oi-yee wong. ms. wong available? then last but not least, sara shortt. are you here? there you are. good morning. >> good morning. i'm just super excited about mental health sf. i'm passionate about being involved in the implementation. i'll tell you why. i think it was probably when i graduated with my masters in social work about 20 years ago when i first started to understand some of the challenges with our mental healthcare system. i knew a bit about it before that. i do have an uncle who's chronically mentally ill. family has been working to get decent care for decades -- understood firsthand all the barriers and the challenges and the obstacles. but also how important it was for him to get decent care. care that emphasized things like harm restructure, care that was sensitive -- coordinated, compassionate. that's what we're talking about with mental health sf. i'm also excited about it because as a member of the treatment on demand coalition, we've been working on the issue of reform for behavio

next, we will hear from aaron buchbinder. are you here? we will hear from oi-yee wong. ms. wong available? then last but not least, sara shortt. are you here? there you are. good morning. >> good morning. i'm just super excited about mental health sf. i'm passionate about being involved in the implementation. i'll tell you why. i think it was probably when i graduated with my masters in social work about 20 years ago when i first started to understand some of the challenges with our mental healthcare system. i knew a bit about it before that. i do have an uncle who's chronically mentally ill. family has been working to get decent care for decades -- understood firsthand all the barriers and the challenges and the obstacles. but also how important it was for him to get decent care. care that emphasized things like harm restructure, care that was sensitive -- coordinated, compassionate. that's what we're talking about with mental health sf. i'm also excited about it because as a member of the treatment on demand coalition, we've been working on the issue of reform for behavio

next, we will hear from aaron buchbinder. are you here? we will hear from oi-yee wong. ms.lable? then last but not least, sara shortt. are you here? there you are. good morning. >> good morning. i'm just super excited about mental health sf. i'm passionate about being involved in the implementation. i'll tell you why. i think it was probably when i graduated with my masters in social work about 20 years ago when i first started to understand some of the challenges with our mental healthcare system. i knew a bit about it before that. i do have an uncle who's chronically mentally ill. family has been working to get decent care for decades -- understood firsthand all the barriers and the challenges and the obstacles. but also how important it was for him to get decent care. care that emphasized things like harm restructure, care that was sensitive -- coordinated, compassionate. that's what we're talking about with mental health sf. i'm also excited about it because as a member of the treatment on demand coalition, we've been working on the issue of reform for behavioral health